Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Late Relapses in Patients Successfully Treated for Thrombotic Thrombocytopenic Purpura1995 · 176 citations
2. 2Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura1998 · 1,775 citations
3. 3Thrombotic thrombocytopenic purpura: 24 years of experience at the American University of Beirut Medical Center2004 · 14 citations
4. 4United States thrombotic thrombocytopenic purpura apheresis study group (US TTP ASG): Multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange1998 · 159 citations
5. 5Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune‐mediated severe ADAMTS13‐deficiency: a report of four cases and a systematic review of the literature2009 · 72 citations